Clinical Trial Working Groups
|
 |
- Trial in start-up: Renal cell carcinoma (Illinois)
- Next call: Friday, April 17 at
10 a.m. ET / 9 a.m. CT.
- Approved LOI: Esophageal (Indiana)
- Current concepts:
- Non-small cell lung cancer (Michigan)
- Non-small cell lung cancer (Indiana) - 2 concepts
- Non-small cell lung cancer with brain metastasis (Minnesota)
- Next call: Thursday, March 26 at
1 p.m. ET / 12 p.m. CT.
-
Trial in start-up: Hepatocellular (Indiana)
- Current concepts:
- Esophageal (Indiana)
- Colorectal (Wisconsin)
- Rectal (Rutgers)
- Pancreatic (Illinois)
- Next call: Thursday, March 12 at 3 p.m. ET / 2 p.m. CT.
- Current concepts:
- First line triple negative metastatic breast cancer (Penn State)
- ER+ and/or PR+ and HER2- breast cancer (Illinois)
- Newly diagnosed ER+, HER2- breast cancer (Minnesota)
- Next call: Tuesday, April 14, at
4 p.m. ET / 3 p.m. CT.
- Seeking second co-chair. If interested, please send your
CV and statement of interest to Zoe Holt.
- Next call: TBD.
- Current concept: Squamous cell carcinoma of the skin (Rutgers)
- Next call: TBD.
Hematology Working Groups
- Current concept: Relapsed/refrectory chronic lymphocytic leukemia (Michigan)
- Seeking second co-chair for Multiple Myeloma. If interested, please send your CV and statement of interest to Zoe Holt.
- Next call: TBD.
|
|
|
|
|
The Big Ten Cancer Research Consortium will host meetings for the BTCRC Steering Committee, Cancer Center Directors, and Clinical Trial Working Groups during ASCO 2015. All meetings listed below will take place at the Holiday Inn Chicago Mart Plaza River North, 350 West Mart Center Drive, Chicago, Ill. See map. Drinks and appetizers will be provided.
- BTCRC Steering Committee Members and Cancer Center Directors: Friday, May 29, 7:00 to 8:30 p.m. CT.
- Melanoma CTWG: Friday, May 29, 8:30 to 9:30 p.m. CT.
- Thoracic CTWG Saturday, May 30, 6:00 to 7:00 p.m. CT.
- Breast CTWG: Saturday, May 30, 7:00 to 8:00 p.m. CT.
- Gastrointestinal CTWG: Saturday, May 30, 7:00 to 8:00 p.m. CT.
- Genitourinary CTWG: Saturday, May 30, 8:30 to 9:30 p.m. CT.
- Gynecologic CTWG: Sunday, May 31, 8:30 to 9:30
p.m. CT.
For more information, contact Zoe Holt at
[email protected], or call 317-634-5842, ext. 30.
|
 Learn about the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, our featured member for March, in this conversation with Director Leonidas Platanias, MD, PhD. Dr. Platanias joined the Northwestern University Feinberg School of Medicine in 2002 as the Lurie Cancer Center's first deputy director and the Jesse, Sara, Andrew, Abigail, Benjamin and Elizabeth Lurie Professor of Oncology. He is also a professor in biochemistry and molecular genetics.
Read more.
To see past member features, click here. |
In this month's Q&A, Big Ten Cancer Research Consortium Administrative Headquarters addresses common questions related to monitoring. These questions include:
- How does a BTCRC monitor prepare for a visit?
- What is the timing of a BTCRC monitoring visit?
- What types of monitoring visits does the BTCRC perform?
- What should a site expect during a BTCRC monitoring visit?
- What is the site pharmacy monitoring process?
- What should I expect after a monitoring visit?
Read our full Q&A. |
What causes cells, as they become cancerous, to switch from aerobic metabolism to glycolysis, which does not require oxygen? How might a more complete understanding of a tumor's "onco-ecosystem" change the way we treat disease? Where will precision medicine and immunotherapy take us in the future? These are just a few of the questions currently being explored at Big Ten cancer centers. Read more.
To see past editions of Across the Consortium, click here.
|
The BTCRC is currently recruiting co-chairs for the following Clinical Trial Working Groups. If you would like to serve as a co-chair for one of these groups, please send your CV and a statement of interest to Zoe Holt at [email protected].
- Gynecologic (seeking one co-chair)
- Multiple Myeloma (seeking one co-chair)
|
|
|
